US Stock MarketDetailed Quotes
CODX Co-diagnostics
- 0.891
- -0.046-4.86%
Close Nov 29 13:00 ET
- 0.895
- +0.004+0.47%
Post 17:01 ET
28.44MMarket Cap-645P/E (TTM)
0.940High0.884Low102.34KVolume0.932Open0.936Pre Close92.41KTurnover0.34%Turnover RatioLossP/E (Static)31.93MShares2.23052wk High0.45P/B26.47MFloat Cap0.88052wk Low--Dividend TTM29.71MShs Float30.990Historical High--Div YieldTTM6.03%Amplitude0.694Historical Low0.902Avg Price1Lot Size
About Co-diagnostics Company
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolCODX
Company NameCo-diagnostics
Listing DateJul 12, 2017
Issue Price6.00
Founded2013
CEOMr. Dwight H Egan
MarketNASDAQ
Employees155
Fiscal Year Ends12-31
Address2401 South Foothill Drive,Suite D
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84109
Phone1-801-438-1036
Websitehttp://www.codiagnostics.com
Company Executives
- Name
- Position
- Salary
- Dwight H Egan
- Chief Executive Officer and Chairman of the Board
- 1.26M
- Brian L. Brown
- Secretary, Chief Financial Officer and Principal Accounting Officer
- 1.04M
- Richard Abbott
- President
- --
- Edward L. Murphy
- Independent Director
- 298.00K
- Richard S. Serbin
- Independent Director
- 298.00K
- James B. Nelson
- Independent Director
- 298.00K
- Dr. Eugene Durenard, Pd.D
- Independent Director
- 298.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
